ATP5IF1

ATP5IF1 (IF1) is a pH-sensitive endogenous inhibitor of the mitochondrial F1Fo-ATP synthase that prevents wasteful ATP hydrolysis when the mitochondrial membrane potential collapses. Structurally, IF1 monomers form dimers via a C-terminal antiparallel α-helical coiled coil; at neutral-to-alkaline pH, dimers further oligomerize into inactive tetramers that mask the N-terminal inhibitory region (residues 14–47), rendering the protein unable to bind the F1 domain (PMID:11742976, PMID:19559621). Beyond its canonical protective role, elevated IF1 expression inhibits ATP synthase activity, causes mitochondrial hyperpolarization, and drives a metabolic shift from oxidative phosphorylation to aerobic glycolysis; the resulting mitochondrial ROS production activates NF-κB signaling—via IκBα degradation and a TRAF1/NIK-dependent non-canonical branch—upregulating Bcl-xL, Snai1, and VEGF to promote cell proliferation, epithelial–mesenchymal transition, and angiogenesis in cancer cells (PMID:20538613, PMID:22342343, PMID:25042864). NF-κB reciprocally drives IF1 transcription, establishing a positive feedback loop that sustains the oncogenic phenotype (PMID:25042864).

1. 2001 High

   Determining how pH controls IF1 activity: the crystal structure revealed that C-terminal coiled-coil dimerization is required for inhibitory competence, while N-terminal oligomerization into tetramers at higher pH masks the inhibitory region, explaining the long-observed pH switch.

   Evidence X-ray crystallography of bovine IF1 at 2.2 Å resolution

   PMID:11742976

   Open questions at the time

   • No atomic-resolution structure of the IF1–F1 inhibited complex
   • Precise pH-sensing residues beyond H49 not fully mapped
   • In vivo stoichiometry of IF1 per ATP synthase complex not established
2. 2010 High

   Establishing IF1 as a direct determinant of the Warburg phenotype: gain- and loss-of-function experiments showed that IF1 expression level controls the balance between oxidative phosphorylation and aerobic glycolysis in cancer cells, with the pH-insensitive H49K mutant confirming the mechanism operates through synthase inhibition.

   Evidence IF1 overexpression (wild-type and H49K mutant) and siRNA knockdown in cancer cell lines with metabolic flux measurements

   PMID:20538613

   Open questions at the time

   • Whether IF1-driven glycolytic shift occurs in non-transformed cells remains untested
   • Contribution of IF1 phosphorylation to metabolic reprogramming not addressed
3. 2012 High

   Identifying the retrograde signaling axis: IF1-induced mitochondrial hyperpolarization generates superoxide that activates NF-κB via IκBα phosphorylation and degradation, driving Bcl-xL upregulation and cell proliferation—a causal chain confirmed by ROS scavenging with MitoQ.

   Evidence IF1 overexpression in colon cancer cells; ROS quantification, NF-κB reporter assays, MitoQ rescue experiments, proliferation assays

   PMID:22342343

   Open questions at the time

   • Identity of the specific mitochondrial ROS source (Complex I vs III) not resolved
   • Whether canonical IKK is the sole kinase mediating IκBα degradation downstream of IF1-ROS unclear
4. 2014 High

   Extending the NF-κB axis to invasion and angiogenesis: in hepatocellular carcinoma, IF1 activates non-canonical NF-κB by promoting TRAF1–NIK association and disrupting TRAF2–cIAP2 control of NIK, leading to NF-κB-dependent transcription of Snai1 (EMT) and VEGF (angiogenesis), with NF-κB reciprocally transcribing IF1 to form a positive feedback loop.

   Evidence Co-immunoprecipitation of TRAF1/TRAF2/NIK complexes; ChIP of NF-κB at Snai1 promoter; siRNA knockdown; in vivo xenograft models in HCC cells

   PMID:25042864

   Open questions at the time

   • How mitochondrial IF1 mechanistically promotes cytoplasmic TRAF1–NIK assembly is unknown
   • Whether the IF1–NF-κB feedback loop operates in non-hepatic cancers not tested
   • Direct IF1 promoter NF-κB binding site not mapped at nucleotide resolution

• The mechanism by which a mitochondrial matrix/inner-membrane protein (IF1) transmits a signal to cytoplasmic NF-κB pathway components beyond ROS remains unresolved, and the physiological relevance of IF1 phosphorylation for regulating its inhibitory or signaling functions is uncharacterized.
• No reconstituted system connecting IF1 to TRAF1/NIK outside of co-IP in cells
• Functional significance of IF1 phosphorylation sites detected by MS not validated
• In vivo genetic models (conditional knockout) for IF1 signaling roles not reported in timeline